Janus kinase inhibitors may be an effective treatment to reduce skin depigmentation in vitiligo

Authors

Shannon E. Lohman, Wayne State University School of MedicineFollow

Abstract

A clinical decision report appraising Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. https://doi.org/10.1016/j.jaad.2017.02.049 for a patient with worsening vitiligo.

DOI

10.22237/crp/1593561900

Creative Commons License

This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License

Recommended Citation

LOHMAN SE. Janus kinase inhibitors may be an effective treatment to reduce skin depigmentation in vitiligo. Clin. Res. Prac. Oct 9 2020;6(2):eP2161. https://doi.org/10.22237/crp/1593561900